Andrew Bresnock

Andrew Bresnock is an accomplished executive with extensive experience in commercial operations and sales management within the healthcare and consumer goods industries. Currently serving as Vice President at MiMedx since March 2017, Andrew leads commercial operations for both U.S. and international teams, overseeing direct sales, distribution, and market access. Prior roles at Eli Lilly and Company included Advisor for the Commercial Operations Biomedicines Business Unit and Director of Six Sigma Black Belt, where Andrew demonstrated expertise in sales force management and operational efficiency. Andrew's career began in sales management within the beverage industry, including positions at Display Technologies and Coca-Cola Enterprises. Educational credentials include an MBA from Milligan College and a Bachelor of Arts in Biblical Studies from Winston Salem Bible College. Core competencies include process efficiency, revenue growth, and organizational change management.